Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1995 Aug 1;309(Pt 3):933–940. doi: 10.1042/bj3090933

Lysophospholipids activate ovarian and breast cancer cells.

Y Xu 1, X J Fang 1, G Casey 1, G B Mills 1
PMCID: PMC1135721  PMID: 7639713

Abstract

We have investigated the effects of phospholipids on activation and proliferation of ovarian and breast cancer cells. Lysophosphatidic acid (LPA), lysophosphatidylserine (LPS) and sphingosylphosphorylcholine (SPC) all induce transient increases in cytosolic free Ca2+ ([Ca2+]i) in both ovarian and breast cancer cell lines. The ability of LPA, LPS and SPC to induce increases in [Ca2+]i in ovarian and breast cancer cells is likely to be due to an interaction with cell-surface receptors as the increases in [Ca2+]i were: (1) due to release of calcium from intracellular stores and not from transmembrane uptake due to changes in permeability; (2) blocked by lanthanum and suramin which do not enter cells; (3) blocked by phorbol esters which interrupt increases in [Ca2+]i induced through a number of different receptors; and (4) not detected in freshly isolated peripheral blood mononuclear cells, indicating cell type specificity. In addition, increases in [Ca2+]i induced by LPA, LPS and SPC in ovarian and breast cancer cells completely self-desensitized and cross-desensitized each other, but did not block increases in [Ca2+]i induced by thrombin. Lysophosphatidylglycerol (LPG), but not other lysophospholipids, inhibited LPA- but not LPS- or SPC-induced increases in [Ca2+]i, suggesting that LPA may interact with a different receptor(s) to LPS or SPC and that their downstream signalling pathways converge or interact. LPA, SPC and LPS also induced rapid increases in tyrosine phosphorylation of specific cellular proteins, including p125FAK. Strikingly, LPA, but not LPS or SPC, induced activation of mitogen-activated protein (MAP) kinases. Despite an ability to activate similar intracellular signaling events, LPA, LPS and SPC exhibited markedly different effects on cell proliferation. Whereas LPA induced a significant increase in cell proliferation, LPS did not substantially alter cell proliferation and SPC inhibited cell proliferation. Surprisingly, phosphatidic acid (PA), which did not induce increases in [Ca2+]i, p125FAK activation or activation of MAP kinases, did induce proliferation of ovarian cancer cells, albeit at higher concentrations that LPA. The discordance between sensitivity to LPG, early biochemical events stimulated, and the eventual proliferation response combine to suggest that LPA probably utilizes a different receptor from LPS, SPC and PA. Therefore ovarian and breast cancer cells are sensitive to the effects of a number of different phospholipids which may play a role in the growth of these tumour cells in the cancer patient and are thus potential targets for therapy.

Full text

PDF
933

Images in this article

939Figure 5
on p.939

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson N. G., Maller J. L., Tonks N. K., Sturgill T. W. Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase. Nature. 1990 Feb 15;343(6259):651–653. doi: 10.1038/343651a0. [DOI] [PubMed] [Google Scholar]
  2. Bacus S. S., Stancovski I., Huberman E., Chin D., Hurwitz E., Mills G. B., Ullrich A., Sela M., Yarden Y. Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells. Cancer Res. 1992 May 1;52(9):2580–2589. [PubMed] [Google Scholar]
  3. Bellini F., Viola G., Menegus A. M., Toffano G., Bruni A. Signalling mechanism in the lysophosphatidylserine-induced activation of mouse mast cells. Biochim Biophys Acta. 1990 Apr 9;1052(1):216–220. doi: 10.1016/0167-4889(90)90079-s. [DOI] [PubMed] [Google Scholar]
  4. Berridge M. J. Inositol trisphosphate and calcium signalling. Nature. 1993 Jan 28;361(6410):315–325. doi: 10.1038/361315a0. [DOI] [PubMed] [Google Scholar]
  5. Boring C. C., Squires T. S., Tong T., Montgomery S. Cancer statistics, 1994. CA Cancer J Clin. 1994 Jan-Feb;44(1):7–26. doi: 10.3322/canjclin.44.1.7. [DOI] [PubMed] [Google Scholar]
  6. Buck L., Axel R. A novel multigene family may encode odorant receptors: a molecular basis for odor recognition. Cell. 1991 Apr 5;65(1):175–187. doi: 10.1016/0092-8674(91)90418-x. [DOI] [PubMed] [Google Scholar]
  7. Buick R. N., Pullano R., Trent J. M. Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res. 1985 Aug;45(8):3668–3676. [PubMed] [Google Scholar]
  8. Casillas A. M., Amaral K., Chegini-Farahani S., Nel A. E. Okadaic acid activates p42 mitogen-activated protein kinase (MAP kinase; ERK-2) in B-lymphocytes but inhibits rather than augments cellular proliferation: contrast with phorbol 12-myristate 13-acetate. Biochem J. 1993 Mar 1;290(Pt 2):545–550. doi: 10.1042/bj2900545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Durieux M. E., Lynch K. R. Signalling properties of lysophosphatidic acid. Trends Pharmacol Sci. 1993 Jun;14(6):249–254. doi: 10.1016/0165-6147(93)90021-b. [DOI] [PubMed] [Google Scholar]
  10. Girolomoni G., Pastore S., Zacchi V., Cavani A., Marconi A., Giannetti A. Phosphatidylserine enhances the ability of epidermal Langerhans cells to induce contact hypersensitivity. J Immunol. 1993 May 15;150(10):4236–4243. [PubMed] [Google Scholar]
  11. Hanahan D. J. Platelet activating factor: a biologically active phosphoglyceride. Annu Rev Biochem. 1986;55:483–509. doi: 10.1146/annurev.bi.55.070186.002411. [DOI] [PubMed] [Google Scholar]
  12. Honda Z., Nakamura M., Miki I., Minami M., Watanabe T., Seyama Y., Okado H., Toh H., Ito K., Miyamoto T. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature. 1991 Jan 24;349(6307):342–346. doi: 10.1038/349342a0. [DOI] [PubMed] [Google Scholar]
  13. Hordijk P. L., Verlaan I., van Corven E. J., Moolenaar W. H. Protein tyrosine phosphorylation induced by lysophosphatidic acid in Rat-1 fibroblasts. Evidence that phosphorylation of map kinase is mediated by the Gi-p21ras pathway. J Biol Chem. 1994 Jan 7;269(1):645–651. [PubMed] [Google Scholar]
  14. Iismaa T. P., Shine J. G protein-coupled receptors. Curr Opin Cell Biol. 1992 Apr;4(2):195–202. doi: 10.1016/0955-0674(92)90033-9. [DOI] [PubMed] [Google Scholar]
  15. Jalink K., Hordijk P. L., Moolenaar W. H. Growth factor-like effects of lysophosphatidic acid, a novel lipid mediator. Biochim Biophys Acta. 1994 Dec 30;1198(2-3):185–196. doi: 10.1016/0304-419x(94)90013-2. [DOI] [PubMed] [Google Scholar]
  16. Kumagai N., Morii N., Fujisawa K., Yoshimasa T., Nakao K., Narumiya S. Lysophosphatidic acid induces tyrosine phosphorylation and activation of MAP-kinase and focal adhesion kinase in cultured Swiss 3T3 cells. FEBS Lett. 1993 Aug 30;329(3):273–276. doi: 10.1016/0014-5793(93)80236-n. [DOI] [PubMed] [Google Scholar]
  17. Landt M., Easom R. A., Colca J. R., Wolf B. A., Turk J., Mills L. A., McDaniel M. L. Parallel effects of arachidonic acid on insulin secretion, calmodulin-dependent protein kinase activity and protein kinase C activity in pancreatic islets. Cell Calcium. 1992 Mar;13(3):163–172. doi: 10.1016/0143-4160(92)90044-s. [DOI] [PubMed] [Google Scholar]
  18. Lenzen S., Görlich J. K., Rustenbeck I. Regulation of transmembrane ion transport by reaction products of phospholipase A2. I. Effects of lysophospholipids on mitochondrial Ca2+ transport. Biochim Biophys Acta. 1989 Jun 26;982(1):140–146. doi: 10.1016/0005-2736(89)90184-3. [DOI] [PubMed] [Google Scholar]
  19. Liscovitch M., Cantley L. C. Lipid second messengers. Cell. 1994 May 6;77(3):329–334. doi: 10.1016/0092-8674(94)90148-1. [DOI] [PubMed] [Google Scholar]
  20. Mazer B. D., Sawami H., Tordai A., Gelfand E. W. Platelet-activating factor-mediated transmembrane signaling in human B lymphocytes is regulated through a pertussis- and cholera toxin-sensitive pathway. J Clin Invest. 1992 Sep;90(3):759–765. doi: 10.1172/JCI115948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Metz S. A. Lysophosphatidylinositol, but not lysophosphatidic acid, stimulates insulin release. A possible role for phospholipase A2 but not de novo synthesis of lysophospholipid in pancreatic islet function. Biochem Biophys Res Commun. 1986 Jul 31;138(2):720–727. doi: 10.1016/s0006-291x(86)80556-3. [DOI] [PubMed] [Google Scholar]
  22. Metz S. A. Mobilization of cellular Ca2+ by lysophospholipids in rat islets of Langerhans. Biochim Biophys Acta. 1988 Feb 22;968(2):239–252. doi: 10.1016/0167-4889(88)90013-4. [DOI] [PubMed] [Google Scholar]
  23. Mills G. B., May C., Hill M., Gelfand E. W. Role of protein kinase C in interleukin 1, anti-T3, and mitogenic lectin-induced interleukin 2 secretion. J Cell Physiol. 1989 Nov;141(2):310–317. doi: 10.1002/jcp.1041410212. [DOI] [PubMed] [Google Scholar]
  24. Mills G. B., May C., McGill M., Roifman C. M., Mellors A. A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action. Cancer Res. 1988 Mar 1;48(5):1066–1071. [PubMed] [Google Scholar]
  25. Monastra G., Pege G., Zanoni R., Toffano G., Bruni A. Lysophosphatidylserine-induced activation of mast cells in mice. J Lipid Mediat. 1991 Jan-Feb;3(1):39–50. [PubMed] [Google Scholar]
  26. Moolenaar W. H., Jalink K., van Corven E. J. Lysophosphatidic acid: a bioactive phospholipid with growth factor-like properties. Rev Physiol Biochem Pharmacol. 1992;119:47–65. doi: 10.1007/3540551921_3. [DOI] [PubMed] [Google Scholar]
  27. Moolenaar W. H. LPA: a novel lipid mediator with diverse biological actions. Trends Cell Biol. 1994 Jun;4(6):213–219. doi: 10.1016/0962-8924(94)90144-9. [DOI] [PubMed] [Google Scholar]
  28. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983 Dec 16;65(1-2):55–63. doi: 10.1016/0022-1759(83)90303-4. [DOI] [PubMed] [Google Scholar]
  29. Needleman P., Turk J., Jakschik B. A., Morrison A. R., Lefkowith J. B. Arachidonic acid metabolism. Annu Rev Biochem. 1986;55:69–102. doi: 10.1146/annurev.bi.55.070186.000441. [DOI] [PubMed] [Google Scholar]
  30. Pouysségur J., Seuwen K. Transmembrane receptors and intracellular pathways that control cell proliferation. Annu Rev Physiol. 1992;54:195–210. doi: 10.1146/annurev.ph.54.030192.001211. [DOI] [PubMed] [Google Scholar]
  31. Rustenbeck I., Lenzen S. Effect of lysophospholipids, arachidonic acid and other fatty acids on regulation of Ca2+ transport in permeabilized pancreatic islets. Cell Calcium. 1992 Apr;13(4):193–202. doi: 10.1016/0143-4160(92)90007-f. [DOI] [PubMed] [Google Scholar]
  32. Seufferlein T., Rozengurt E. Lysophosphatidic acid stimulates tyrosine phosphorylation of focal adhesion kinase, paxillin, and p130. Signaling pathways and cross-talk with platelet-derived growth factor. J Biol Chem. 1994 Mar 25;269(12):9345–9351. [PubMed] [Google Scholar]
  33. Ye R. D., Prossnitz E. R., Zou A. H., Cochrane C. G. Characterization of a human cDNA that encodes a functional receptor for platelet activating factor. Biochem Biophys Res Commun. 1991 Oct 15;180(1):105–111. doi: 10.1016/s0006-291x(05)81261-6. [DOI] [PubMed] [Google Scholar]
  34. Yoshimasa T., Nakao K., Suga S., Kishimoto I., Kiso Y., Imura H. Identification and endothelin-induced activation of multiple extracellular signal-regulated kinases in aortic smooth muscle cells. FEBS Lett. 1992 Oct 26;311(3):195–198. doi: 10.1016/0014-5793(92)81100-z. [DOI] [PubMed] [Google Scholar]
  35. van Corven E. J., Groenink A., Jalink K., Eichholtz T., Moolenaar W. H. Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell. 1989 Oct 6;59(1):45–54. doi: 10.1016/0092-8674(89)90868-4. [DOI] [PubMed] [Google Scholar]
  36. van Corven E. J., van Rijswijk A., Jalink K., van der Bend R. L., van Blitterswijk W. J., Moolenaar W. H. Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin. Biochem J. 1992 Jan 1;281(Pt 1):163–169. doi: 10.1042/bj2810163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. van der Bend R. L., Brunner J., Jalink K., van Corven E. J., Moolenaar W. H., van Blitterswijk W. J. Identification of a putative membrane receptor for the bioactive phospholipid, lysophosphatidic acid. EMBO J. 1992 Jul;11(7):2495–2501. doi: 10.1002/j.1460-2075.1992.tb05314.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES